Board of Directors

Richard Jackson, PhD
Chairman of the Board
CEO of Ausio Pharmaceuticals.  Dr. Jackson is also on the Board of Directors of Biomira Inc., a biotechnology company specializing in the development of therapeutic approaches to cancer management.  Dr. Jackson was the President and CEO of Emergen, Inc., where he led creation of a leading women's health care company.  Over his career, Dr. Jackson also held the positions of Senior Vice President, Research and Development, at Atrix Laboratories Inc., Senior Vice President, Discovery Research, at Wyeth-Ayerst, and Vice President, Research Sciences, at Marion Merrell Dow Research Institute. Dr. Jackson received his PhD in Microbiology from the University of Illinois, and his Bachelor of Science in Chemistry from the University of Illinois.

Cameron Durrant, MD, MBA
Dr. Durrant is Worldwide Vice President, Virology Global Strategic Marketing, J&J.  Previously, he was President and CEO of PediaMed Pharmaceuticals , a privately-held specialty pharmaceuticals company, where he tripled sales, and increased market capitalization over six-fold. He was formerly Vice President and Head of Global Business Planning and Operations; Vice President and Head of Global Infectious Diseases at Pharmacia Corporation (now Pfizer). Dr. Durrant also held leadership positions at GlaxoSmithKline and Merck and Co. Dr. Durrant earned his MBA at Henley Management College in Oxford, and earned his MB and BCh (equivalent to US MD degree) from the Welsh National School of Medicine in Cardiff.

Ray Takigiku, PhD
President and CEO of Bexion Pharmaceuticals